After several decades of peaks and troughs, corporate venturers feel they are climbing up the slope of enlightenment.

UCL Business and the UCL Technology Fund have both contributed to a series A round for biotech company Orchard Therapeutics.

"I have accepted a new job as a managing partner with a Sand Hill Road based private venture capital firm. May 20th is my last day at Intel Capital."

SEB and ABN Amro made strategic investments as part of the personal finances app developer's series B round, which will fund the next iteration of its product.

Founders Factory will build and develop more than 200 startups over five years, with Aviva supporting seven companies each year through 2021.

The Russia-based cybersecurity software producer, which launched an accelerator last year, will invest up to $1m in strategically relevant startups.

The immuno-oncology drug developer, backed by several pharmaceutical firms, has raised $55m in an IPO that saw it float substantially below its $14 to $16 range.

Researchers at Cambridge University have created the first nano-engine and are now hoping to commercialise the technology.